Page last updated: 2024-11-03

promethazine and Osteoporosis, Postmenopausal

promethazine has been researched along with Osteoporosis, Postmenopausal in 1 studies

Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tyan, ML1

Trials

1 trial available for promethazine and Osteoporosis, Postmenopausal

ArticleYear
Effect of promethazine on lumbar vertebral bone mass in postmenopausal women.
    Journal of internal medicine, 1993, Volume: 234, Issue:2

    Topics: Absorptiometry, Photon; Aged; Analysis of Variance; Bone Density; Female; Humans; Lumbar Vertebrae;

1993